Paper17530362
Type IV collagen 7s domain is an independent clinical marker of the severity of fibrosis in patients with nonalcoholic steatohepatitis before the cirrhotic stage.
Yoneda M and 16 others. J Gastroenterol, 2007. Cited by 80 papers, by iCite.
Cite this record
ConductScience Library. Type IV collagen 7s domain is an independent clinical marker of the severity of fibrosis in patients with nonalcoholic steatohepatitis before the cirrhotic stage. Papers, record 17530362. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17530362
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Type IV collagen 7s domain is an independent clinical marker of the severity of fibrosis in patients with nonalcoholic steatohepatitis before the cirrhotic stage.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Collagen Type IV | Major topic |
| Fatty Liver | Major topic |
| Adult | |
| Disease Progression | |
| Female | |
| Fibrosis | |
| Humans | |
| Hyaluronic Acid | |
| Insulin Resistance | |
| Liver | |
| Logistic Models | |
| Male | |
| Middle Aged | |
| Multivariate Analysis | |
| ROC Curve |
Source PubMed
References31
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15605303 | Clinical aspects of fatty liver disease. | Semin Liver Dis | 2004 | https://conductscience.org/library/papers/15605303 | PubMed |
| 2 | 12542595 | Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region? | J Gastroenterol Hepatol | 2003 | https://conductscience.org/library/papers/12542595 | PubMed |
| 3 | 7489979 | The natural history of nonalcoholic fatty liver: a follow-up study. | Hepatology | 1995 | https://conductscience.org/library/papers/7489979 | PubMed |
| 4 | 12883486 | Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C. | Hepatology | 2003 | https://conductscience.org/library/papers/12883486 | PubMed |
| 5 | 10833486 | Liver fibrosis in overweight patients. | Gastroenterology | 2000 | https://conductscience.org/library/papers/10833486 | PubMed |
| 6 | 10888734 | Appropriateness of liver biopsy. | Can J Gastroenterol | 2000 | https://conductscience.org/library/papers/10888734 | PubMed |
| 7 | 10573511 | Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. | Hepatology | 1999 | https://conductscience.org/library/papers/10573511 | PubMed |
| 8 | 9839117 | Correct homeostasis model assessment (HOMA) evaluation uses the computer program. | Diabetes Care | 1998 | https://conductscience.org/library/papers/9839117 | PubMed |
| 9 | 11522755 | Nonalcoholic steatohepatitis. | Gastroenterology | 2001 | https://conductscience.org/library/papers/11522755 | PubMed |
| 10 | 1631498 | Significance of serum type-IV collagen levels in various liver diseases. Measurement with a one-step sandwich enzyme immunoassay using monoclonal antibodies with specificity for pepsin-solubilized type-IV collagen. | Scand J Gastroenterol | 1992 | https://conductscience.org/library/papers/1631498 | PubMed |
| 11 | 11961152 | Nonalcoholic fatty liver disease. | N Engl J Med | 2002 | https://conductscience.org/library/papers/11961152 | PubMed |
| 12 | 1455153 | Serum hyaluronan and aminoterminal propeptide of type III procollagen: variation with age. | Scand J Clin Lab Invest | 1992 | https://conductscience.org/library/papers/1455153 | PubMed |
| 13 | 15633226 | Clinical usefulness of biochemical markers of liver fibrosis in patients with nonalcoholic fatty liver disease. | World J Gastroenterol | 2005 | https://conductscience.org/library/papers/15633226 | PubMed |
| 14 | 12404245 | AGA technical review on nonalcoholic fatty liver disease. | Gastroenterology | 2002 | https://conductscience.org/library/papers/12404245 | PubMed |
| 15 | 12434092 | [Good clinical practice guidelines for fine needle aspiration biopsy of the liver: past, present and future]. | Gastroenterol Clin Biol | 2002 | https://conductscience.org/library/papers/12434092 | PubMed |
| 16 | 7382552 | Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. | Mayo Clin Proc | 1980 | https://conductscience.org/library/papers/7382552 | PubMed |
| 17 | 12883497 | A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. | Hepatology | 2003 | https://conductscience.org/library/papers/12883497 | PubMed |
| 18 | 12472968 | Treatment of non-alcoholic fatty liver disease. | J Gastroenterol Hepatol | 2002 | https://conductscience.org/library/papers/12472968 | PubMed |
| 19 | 3410220 | Alcohollike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury. | Gastroenterology | 1988 | https://conductscience.org/library/papers/3410220 | PubMed |
| 20 | 10348825 | Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. | Gastroenterology | 1999 | https://conductscience.org/library/papers/10348825 | PubMed |
Cited by41
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 80 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42952688 | Analysis of pathogenesis-related factors of Streptococcus mutans from the oral cavity of patients with nonalcoholic steatohepatitis. | Front Immunol | 2026 | https://conductscience.org/library/papers/42952688 | PubMed |
| 42315674 | CLEIA-based type IV collagen 7S for second-step assessment of MRE-defined clinically significant fibrosis in MASLD with indeterminate FIB-4. | Sci Rep | 2026 | https://conductscience.org/library/papers/42315674 | PubMed |
| 40832563 | Echocardiographic measurement of inferior vena cava diameter for estimating central venous pressure in adult Fontan patients. | Eur Heart J Imaging Methods Pract | 2025 | https://conductscience.org/library/papers/40832563 | PubMed |
| 39055237 | Identification of risk groups for advanced liver fibrosis in the general population using the Fibrosis-3 index. | JGH Open | 2024 | https://conductscience.org/library/papers/39055237 | PubMed |
| 39035406 | Serologic Biomarkers for Hepatic Fibrosis in Obese Children with Nonalcoholic Steatohepatitis. | Pediatr Gastroenterol Hepatol Nutr | 2024 | https://conductscience.org/library/papers/39035406 | PubMed |
| 37842727 | Recent Advances in the Pathogenesis and Clinical Evaluation of Portal Hypertension in Chronic Liver Disease. | Gut Liver | 2024 | https://conductscience.org/library/papers/37842727 | PubMed |
| 36326882 | Liver stiffness assessed by magnetic resonance elastography predicts clinical outcomes in patients with heart failure and without chronic liver disease. | Eur Radiol | 2023 | https://conductscience.org/library/papers/36326882 | PubMed |
| 36307441 | A 3-step approach to predict advanced fibrosis in nonalcoholic fatty liver disease: impact on diagnosis, patient burden, and medical costs. | Sci Rep | 2022 | https://conductscience.org/library/papers/36307441 | PubMed |
| 35822119 | Efficacy and safety of oral semaglutide in patients with non-alcoholic fatty liver disease complicated by type 2 diabetes mellitus: A pilot study. | JGH Open | 2022 | https://conductscience.org/library/papers/35822119 | PubMed |
| 35352460 | Noninvasive assessment of liver fibrosis and its clinical significance in nonalcoholic fatty liver disease. | Hepatol Res | 2022 | https://conductscience.org/library/papers/35352460 | PubMed |
| 35204498 | Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches. | Diagnostics (Basel) | 2022 | https://conductscience.org/library/papers/35204498 | PubMed |
| 34131471 | Combination of type IV collagen 7S, albumin concentrations, and platelet count predicts prognosis of non-alcoholic fatty liver disease. | World J Hepatol | 2021 | https://conductscience.org/library/papers/34131471 | PubMed |
| 34105780 | Transcriptomics Identify Thrombospondin-2 as a Biomarker for NASH and Advanced Liver Fibrosis. | Hepatology | 2021 | https://conductscience.org/library/papers/34105780 | PubMed |
| 34064337 | Correlation between Liver Stiffness by Two-Dimensional Shear Wave Elastography and Waist Circumference in Japanese Local Citizens with Abdominal Obesity. | J Clin Med | 2021 | https://conductscience.org/library/papers/34064337 | PubMed |
| 33857552 | Cellular protein markers, therapeutics, and drug delivery strategies in the treatment of diabetes-associated liver fibrosis. | Adv Drug Deliv Rev | 2021 | https://conductscience.org/library/papers/33857552 | PubMed |
| 33829335 | Predictive scoring system for advanced liver fibrosis in Japanese patients with severe obesity. | Surg Today | 2021 | https://conductscience.org/library/papers/33829335 | PubMed |
| 32570776 | Epidemiology: Pathogenesis, and Diagnostic Strategy of Diabetic Liver Disease in Japan. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32570776 | PubMed |
| 32329963 | Comparison of the effects of three kinds of glucose-lowering drugs on non-alcoholic fatty liver disease in patients with type 2 diabetes: A randomized, open-label, three-arm, active control study. | J Diabetes Investig | 2020 | https://conductscience.org/library/papers/32329963 | PubMed |
| 31933238 | Applying Non-Invasive Fibrosis Measurements in NAFLD/NASH: Progress to Date. | Pharmaceut Med | 2019 | https://conductscience.org/library/papers/31933238 | PubMed |
| 31721770 | Factors influencing subclinical atherosclerosis in patients with biopsy-proven nonalcoholic fatty liver disease. | PLoS One | 2019 | https://conductscience.org/library/papers/31721770 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17530362
GET https://conductscience.org/api/papers/v1/17530362/references?page=2